Clinical benefits of steroid-therapy on surgical stress in patients with esophageal cancer

Surgery

Volumn 128, Issue 5, 2000, Pages 791-798

  Shimada, Hideaki ^a   Ochiai, Takenori ^a   Okazumi, Shin Ichi ^a   Matsubara, Hisahiro ^a   Nabeya, Yoshihiro ^a   Miyazawa, Yukimasa ^a   Arima, Miwako ^a   Funami, Yutaka ^a   Hayashi, Hideki ^a   Takeda, Akihiko ^a   Gunji, Yoshio ^a   Suzuki, Takao ^a   Kobayashi, Susumu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; METHYLPREDNISOLONE; STEROID;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BODY TEMPERATURE; BREATHING RATE; CONTROLLED STUDY; CYTOKINE RELEASE; ESOPHAGUS CANCER; FEMALE; HEART RATE; HUMAN; HYPERBILIRUBINEMIA; INFLAMMATION; LENGTH OF STAY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POLYMORPHONUCLEAR CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SIDE EFFECT; STEROID THERAPY; SURGICAL STRESS;

EID: 0033757826     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.108614     Document Type: Article

References (30)

1. Diagnosis and surgery of esophageal cancer
2. Modern trends in surgical management of intrathoracic esophageal cancer
3. The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy
4. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer
5. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma
6. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy
7. Infuence of surgical stress on bactericidal activity of neutrophils and complications of infection in patients with esophageal cancer
8. Influence of surgical stress on monocytes and complications of infection in patients with esophageal cancer-monocyte HLA-DR antigen expression and respiratory burst capacity
9. Prediction of postoperative pulmonary complications in esophago-gastric cancer surgery
10. Postoperative hyperbilirubinemia after resection of thoracic esophageal cancer
11. Postoperative pulmonary complications in patients with esophageal cancer
12. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity
13. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?
14. Elevation of circulating interleukin 6 after surgery: Factors influencing the serum level
15. Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major abdominal surgery
16. Elevation of serum interleukin-6 prior to acute phase proteins on the inflammation by surgical operation
17. Intedeukin-6 as a new indicator of inflammatory status: Detection of serum levels of interleukin-6 and C-reactive protein after surgery
18. Pulmonary hypertension and polymorphonuclear leukocyte elastase after esophageal cancer operations
19. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts
20. Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice
21. Control of the excessive reaction after surgery for esophageal carcinoma with preoperative administration of the corticosteroids (in Japanese with English abstract)
22. The effect of a perioperative steroid pulse on surgical stress in hepatic resection
23. Glucocorticoid attenuates a decrease of antithrombin III following major surgery
24. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
25. Effect of methylprednisolone on the cytokine response in patients undergoing lung surgery
26. An enzyme-linked immunosorbent assay for the measurement of human interleukin-6
27. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
28. Mechanisms of the development of organ failure following surgical insult: The 'second attack' theory
29. Sir Isaac Newton, sepsis, SIRS, and CARS